- Home
- NL vs PRQR Comparison
NL vs PRQR Comparison
Compare NL & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NL
- PRQR
- Stock Information
- Founded
- NL 1891
- PRQR 2012
- Country
- NL United States
- PRQR Netherlands
- Employees
- NL N/A
- PRQR N/A
- Industry
- NL Major Chemicals
- PRQR Biotechnology: Pharmaceutical Preparations
- Sector
- NL Industrials
- PRQR Health Care
- Exchange
- NL Nasdaq
- PRQR Nasdaq
- Market Cap
- NL 341.3M
- PRQR 309.5M
- IPO Year
- NL N/A
- PRQR 2014
- Fundamental
- Price
- NL $8.13
- PRQR $3.62
- Analyst Decision
- NL Sell
- PRQR Strong Buy
- Analyst Count
- NL 1
- PRQR 4
- Target Price
- NL $6.00
- PRQR $7.13
- AVG Volume (30 Days)
- NL 28.5K
- PRQR 635.3K
- Earning Date
- NL 11-06-2024
- PRQR 11-07-2024
- Dividend Yield
- NL 3.95%
- PRQR N/A
- EPS Growth
- NL N/A
- PRQR N/A
- EPS
- NL 1.19
- PRQR N/A
- Revenue
- NL $150,690,000.00
- PRQR $20,506,357.00
- Revenue This Year
- NL $2.18
- PRQR $298.83
- Revenue Next Year
- NL $2.50
- PRQR N/A
- P/E Ratio
- NL $6.80
- PRQR N/A
- Revenue Growth
- NL N/A
- PRQR 306.68
- 52 Week Low
- NL $4.46
- PRQR $1.18
- 52 Week High
- NL $8.93
- PRQR $4.62
- Technical
- Relative Strength Index (RSI)
- NL 55.59
- PRQR 54.60
- Support Level
- NL $7.51
- PRQR $3.57
- Resistance Level
- NL $8.17
- PRQR $3.70
- Average True Range (ATR)
- NL 0.43
- PRQR 0.22
- MACD
- NL -0.01
- PRQR -0.08
- Stochastic Oscillator
- NL 52.54
- PRQR 18.06
About NL NL Industries Inc.
NL Industries Inc operates in the component products industry through its majority-owned subsidiary, CompX International Inc. It manufactures engineered components that are sold to a range of industries, including recreational transportation, postal, office and institutional furniture, cabinetry, tool storage, healthcare, gas stations and vending equipment. CompX has three production facilities in the United States, through which it produces a precision ball bearing slide, security products, and ergonomic computer support systems. The company derives majority of its revenue from Europe.
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.